• 1. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277

Comprehensive Overview of 2,8-Diazaspiro[5.5]undecane (CAS No. 180-50-7): Properties, Applications, and Industry Insights

2,8-Diazaspiro[5.5]undecane (CAS No. 180-50-7) is a heterocyclic organic compound featuring a unique spirocyclic structure, which has garnered significant attention in pharmaceutical and chemical research. Its molecular framework combines two nitrogen atoms within a bridged ring system, making it a versatile intermediate for synthesizing bioactive molecules. The compound’s rigid geometry and dual nitrogen sites enable diverse functionalization, aligning with modern drug discovery trends targeting GPCRs and enzyme inhibitors.

Recent studies highlight the role of 2,8-Diazaspiro[5.5]undecane in developing CNS therapeutics, particularly for neurodegenerative diseases like Alzheimer’s and Parkinson’s. Researchers are exploring its potential as a scaffold for neuroprotective agents, leveraging its ability to cross the blood-brain barrier. This aligns with growing public interest in brain health supplements and cognitive enhancers, as evidenced by rising searches for "nootropic compounds" and "neurotransmitter modulators."

From a synthetic chemistry perspective, CAS 180-50-7 serves as a building block for peptidomimetics, addressing demands in peptide-based drug design. Its spirocyclic core mimics natural peptide conformations, a hotspot in oncology and metabolic disorder research. Industry reports note its utility in creating PROTACs (Proteolysis-Targeting Chimeras), a revolutionary approach in targeted protein degradation therapies.

Environmental and regulatory considerations are also critical. The compound’s low ecotoxicity profile and biodegradability make it suitable for green chemistry initiatives, resonating with the global push for sustainable pharmaceuticals. Analysts correlate this with increased searches for "eco-friendly chemical synthesis" and "FDA-approved green solvents."

In material science, derivatives of 2,8-Diazaspiro[5.5]undecane exhibit ligand properties for metal-organic frameworks (MOFs), relevant to carbon capture technologies—a trending topic amid climate change debates. Its chelate-forming ability is being tested in catalysis and sensor development, answering industry needs for high-efficiency catalysts.

Market projections indicate growth for CAS 180-50-7, driven by pharmaceutical outsourcing and custom synthesis demands. Startups focusing on AI-driven molecular design frequently include this compound in libraries for virtual screening, reflecting its relevance in computational chemistry.

To conclude, 2,8-Diazaspiro[5.5]undecane exemplifies the convergence of medicinal chemistry, sustainability, and advanced materials. Its multifaceted applications—from drug discovery to clean energy—position it as a compound of enduring scientific and commercial value.

• 58324-99-5(3,7-Diazabicyclo[3.3.1]nonane, 3-methyl-)
• 90203-05-7(N,N-Dimethyl-1-piperidin-3-ylmethanamine)
• 724695-93-6(4,4-Piperidinedimethanamine,1-methyl-(9CI))
• 14613-37-7((1-methyl-3-piperidyl)methanamine)
• 14156-91-3(3-(3-Methylpiperidin-1-yl)propan-1-amine)
• 6238-38-6(1-Azabicyclo[2.2.2]octane-3-methanamine,N,N-dimethyl-)
• 909037-18-9(3,7-Dipropyl-3,7-diazabicyclo[3.3.1]nonane)
• 14789-33-4(3,7-Diazabicyclo[3.3.1]nonane,3,7-dimethyl-)
• 254905-65-2((R)-N,N-Dimethyl-1-(piperidin-3-yl)methanamine)
• 120990-84-3(Diethyl-piperidin-3-ylmethyl-amine)